Drivers of Irrational Use of Antibiotics in Europe

Anna Machowska, Cecilia Stålsby Lundborg, Anna Machowska, Cecilia Stålsby Lundborg

Abstract

The unnecessary use of antibiotics and concomitant rapid growth of antibiotic resistance (ABR) is a widely acknowledged threat to global health, development, and sustainability. While the underlying cause of ABR is undoubtedly the overall volume of antibiotic use in general, irrational antibiotic use, which is influenced by several interrelated factors, is a major contributory factor. Here, we aimed to present and describe selected main drivers of irrational use of antibiotics in Europe. We performed a broad search of the current literature in databases such as PubMed, Google Scholar, Cochrane, as well as various institutional websites (World Health Organization, European Observatory, European Commission) to provide a new perspective on selected drivers of irrational antibiotic use in Europe. We also searched for relevant literature using snowballing, i.e., using reference lists of papers to identify additional papers. In this narrative review, we present that major factors among the general public driving antibiotic resistance are lack of public knowledge and awareness, access to antibiotics without prescription and leftover antibiotics, and knowledge attitude and perception of prescribers and dispensers, inadequate medical training, pharmaceutical promotion, lack of rapid and sufficient diagnostic tests, and patient⁻doctor interaction as major factors among healthcare providers. We further discuss initiatives that, if taken and implemented, can have an impact on and improve the current situation in Europe.

Keywords: Europe; antibiotic resistance; antibiotics; irrational use; unnecessary antibiotic use.

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.

Figures

Figure 1
Figure 1
Examples of drivers or irrational antibiotic use in Europe.

References

    1. Sengupta S., Chattopadhyay M.K., Grossart H.P. The multifaceted roles of antibiotics and antibiotic resistance in nature. Front. Microbiol. 2013;4:47. doi: 10.3389/fmicb.2013.00047.
    1. Ventola C.L. The antibiotic resistance crisis: Part 1: Causes and threats. Pharm. Ther. 2015;40:277–283.
    1. World Health Organization . The World Medicines Situation. World Health Organization; Geneva, Switzerland: 2011.
    1. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) European Centre for Disease Prevention and Control; Stockholm, Sweden: 2018. Surveillance of Antimicrobial Resistance in Europe 2017.
    1. European Centre for Disease Prevention and Control . Annual Epidemiological Report for 2016. European Centre for Disease Prevention and Control; Stockholm, Sweden: 2018.
    1. O’Neill J. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. The Review on Antimicrobial Resistance; London, UK: 2014.
    1. World Health Organization . Global Action Plan on Antimicrobial Resistance. World Health Organization; Geneva, Switzerland: 2015.
    1. Tenover F.C. Mechanisms of antimicrobial resistance in bacteria. Am. J. Med. 2006;119(Suppl. 1):S3–S10. doi: 10.1016/j.amjmed.2006.03.011.
    1. Van Boeckel T.P., Gandra S., Ashok A., Caudron Q., Grenfell B.T., Levin S.A., Laxminarayan R. Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data. Lancet Infect. Dis. 2014;14:742–750. doi: 10.1016/S1473-3099(14)70780-7.
    1. Morgan D.J., Okeke I.N., Laxminarayan R., Perencevich E.N., Weisenberg S. Non-prescription antimicrobial use worldwide: A systematic review. Lancet Infect. Dis. 2011;11:692–701. doi: 10.1016/S1473-3099(11)70054-8.
    1. World Health Organization . Global Strategy for Containment of Antimicrobial Resistance. World Health Organization; Geneva, Switzerland: 2001.
    1. European Commission . Special Eurobarometer 445: Antimicrobial Resistance. European Commission; Brussels, Belgium: 2016.
    1. Henricson K., Melander E., Molstad S., Ranstam J., Hanson B.S., Rametsteiner G., Stenberg P., Melander A. Intra-urban variation of antibiotic utilization in children: Influence of socio-economic factors. Eur. J. Clin. Pharmacol. 1998;54:653–657. doi: 10.1007/s002280050529.
    1. McCullough A.R., Parekh S., Rathbone J., Del Mar C.B., Hoffmann T.C. A systematic review of the public’s knowledge and beliefs about antibiotic resistance. J. Antimicrob. Chemother. 2016;71:27–33. doi: 10.1093/jac/dkv310.
    1. Grigoryan L., Burgerhof J.G., Degener J.E., Deschepper R., Lundborg C.S., Monnet D.L., Scicluna E.A., Birkin J., Haaijer-Ruskamp F.M., et al. Attitudes, beliefs and knowledge concerning antibiotic use and self-medication: A comparative European study. Pharmacoepidemiol. Drug Saf. 2007;16:1234–1243. doi: 10.1002/pds.1479.
    1. Pavyde E., Veikutis V., Maciuliene A., Maciulis V., Petrikonis K., Stankevicius E. Public knowledge, beliefs and behavior on antibiotic use and self-medication in Lithuania. Int. J. Environ. Res. Public Health. 2015;12:7002–7016. doi: 10.3390/ijerph120607002.
    1. Ramalhinho I., Cordeiro C., Cavaco A., Cabrita J. Assessing determinants of self-medication with antibiotics among Portuguese people in the Algarve Region. Int. J. Clin Pharm. 2014;36:1039–1047. doi: 10.1007/s11096-014-9992-z.
    1. Llor C., Cots J.M. The sale of antibiotics without prescription in pharmacies in Catalonia, Spain. Clin. Infect. Dis. 2009;48:1345–1349. doi: 10.1086/598183.
    1. Both L., Botgros R., Cavaleri M. Analysis of licensed over-the-counter (OTC) antibiotics in the European Union and Norway, 2012. Euro Surveill. 2015;20:30002. doi: 10.2807/1560-7917.ES.2015.20.34.30002.
    1. European Commission . ANTIMICROBIAL RESISTANCE and Causes of Non-Prudent Use of Antibiotics in Human Medicine in the EU. European Commission; Brussels, Belgium: 2016.
    1. Wilkinson J. The Community Pharmacy Contribution to Tackling Antimicrobial Resistance (AMR) Pharmaceutical Group of the European Union (PGEU); Brussels, Belgium: 2017.
    1. McNulty C.A., Boyle P., Nichols T., Clappison D.P., Davey P. Antimicrobial drugs in the home, United Kingdom. Emerg. Infect. Dis. 2006;12:1523–1526. doi: 10.3201/eid1210.051471.
    1. Lambert H.P. Don’t keep taking the tablets? Lancet. 1999;354:943–945. doi: 10.1016/S0140-6736(99)01139-3.
    1. Magee J.T. The resistance ratchet: Theoretical implications of cyclic selection pressure. J. Antimicrob. Chemother. 2005;56:427–430. doi: 10.1093/jac/dki229.
    1. Gonzalez-Gonzalez C., Lopez-Vazquez P., Vazquez-Lago J.M., Pineiro-Lamas M., Herdeiro M.T., Arzamendi P.C., Figueiras A., GREPHEPI Group Effect of physicians’ attitudes and knowledge on the quality of antibiotic prescription: A. cohort study. PLoS ONE. 2015;10:e0141820. doi: 10.1371/journal.pone.0141820.
    1. Molstad S., Lofmark S., Carlin K., Erntell M., Aspevall O., Blad L., Hanberger H., Hedin K., Hellman J., Norman C., et al. Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance. Bull. World Health Organ. 2017;95:764–773. doi: 10.2471/BLT.16.184374.
    1. McCullough A.R., Rathbone J., Parekh S., Hoffmann T.C., Del Mar C.B. Not in my backyard: A systematic review of clinicians’ knowledge and beliefs about antibiotic resistance. J. Antimicrob. Chemother. 2015;70:2465–2473. doi: 10.1093/jac/dkv164.
    1. Bjorkman I., Berg J., Viberg N., Stalsby Lundborg C. Awareness of antibiotic resistance and antibiotic prescribing in UTI treatment: A qualitative study among primary care physicians in Sweden. Scand. J. Prim. Health Care. 2013;31:50–55. doi: 10.3109/02813432.2012.751695.
    1. Teixeira Rodrigues A., Ferreira M., Pineiro-Lamas M., Falcao A., Figueiras A., Herdeiro M.T. Determinants of physician antibiotic prescribing behavior: A 3 year cohort study in Portugal. Curr. Med. Res. Opin. 2016;32:949–957. doi: 10.1185/03007995.2016.1154520.
    1. Dyar O.J., Nathwani D., Monnet D.L., Gyssens I.C., Stalsby Lundborg C., Pulcini C., Wechsler-Fördös A., Kostyanev T., Vlahović-Palčevski V., Kolar M., et al. Do medical students feel prepared to prescribe antibiotics responsibly? Results from a cross-sectional survey in 29 European countries. J. Antimicrob. Chemother. 2018;73:2236–2242. doi: 10.1093/jac/dky150.
    1. Gharbi M., Moore L.S., Castro-Sanchez E., Spanoudaki E., Grady C., Holmes A.H., Drumright L.N. A needs assessment study for optimising prescribing practice in secondary care junior doctors: The Antibiotic Prescribing Education among Doctors (APED) BMC Infect. Dis. 2016;16:456. doi: 10.1186/s12879-016-1800-z.
    1. WHO/HAI . Understanding and Responding to Pharmaceutical Promotion: A Practical Guide. WHO/HAI; London, UK: 2009.
    1. Spurling G.K., Mansfield P.R., Montgomery B.D., Lexchin J., Doust J., Othman N., Vitry A.I., Othman N. Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: A systematic review. PLoS Med. 2010;7:e1000352. doi: 10.1371/journal.pmed.1000352.
    1. Lieb K., Scheurich A. Contact between doctors and the pharmaceutical industry, their perceptions, and the effects on prescribing habits. PLoS ONE. 2014;9:e110130. doi: 10.1371/journal.pone.0110130.
    1. Vazquez-Lago J.M., Lopez-Vazquez P., Lopez-Duran A., Taracido-Trunk M., Figueiras A. Attitudes of primary care physicians to the prescribing of antibiotics and antimicrobial resistance: A qualitative study from Spain. Fam. Pract. 2012;29:352–360. doi: 10.1093/fampra/cmr084.
    1. Kerremans J.J., Verboom P., Stijnen T., Hakkaart-van Roijen L., Goessens W., Verbrugh H.A., Vos M.C. Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J. Antimicrob. Chemother. 2008;61:428–435. doi: 10.1093/jac/dkm497.
    1. Huang A.M., Newton D., Kunapuli A., Gandhi T.N., Washer L.L., Isip J., Collins C.D., Nagel J.L. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin. Infect. Dis. 2013;57:1237–1245. doi: 10.1093/cid/cit498.
    1. Vincent J.L., Brealey D., Libert N., Abidi N.E., O’Dwyer M., Zacharowski K., Mikaszewska-Sokolewicz M., Schrenzel J., Simon F., Wilks M., et al. Rapid diagnosis of infection in the Critically Ill, a multicenter study of molecular detection in bloodstream infections, pneumonia, and sterile site infections. Crit. Care Med. 2015;43:2283–2291. doi: 10.1097/CCM.0000000000001249.
    1. Banerjee R., Teng C.B., Cunningham S.A., Ihde S.M., Steckelberg J.M., Moriarty J.P., Shah N.D., Mandrekar J.N., Patel R. Randomized trial of rapid multiplex polymerase chain r eaction-based blood culture identification and susceptibility testing. Clin. Infect. Dis. 2015;61:1071–1080. doi: 10.1093/cid/civ447.
    1. World Health Organization . Global Antimicrobial Resistance Surveillance System (GLASS) Report. World Health Organization; Geneva, Switzerland: 2017. Early Implementation.
    1. Butler C.C., Rollnick S., Pill R., Maggs-Rapport F., Stott N. Understanding the culture of prescribing: Qualitative study of general practitioners’ and patients’ perceptions of antibiotics for sore throats. BMJ. 1998;317:637–642. doi: 10.1136/bmj.317.7159.637.
    1. Cole A. GPs feel pressurised to prescribe unnecessary antibiotics, survey finds. BMJ. 2014;349:g5238. doi: 10.1136/bmj.g5238.
    1. Costelloe C., Metcalfe C., Lovering A., Mant D., Hay A.D. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis. BMJ. 2010;340:c2096. doi: 10.1136/bmj.c2096.
    1. van der Velden A.W., Pijpers E.J., Kuyvenhoven M.M., Tonkin-Crine S.K., Little P., Verheij T.J. Effectiveness of physician-targeted interventions to improve antibiotic use for respiratory tract infections. Br. J. Gen Pract. 2012;62:e801–e807. doi: 10.3399/bjgp12X659268.
    1. Fernandez Urrusuno R., Flores Dorado M., Vilches Arenas A., Serrano Martino C., Corral Baena S., Montero Balosa M.C. Improving the appropriateness of antimicrobial use in primary care after implementation of a local antimicrobial guide in both levels of care. Eur. J. Clin Pharmacol. 2014;70:1011–1020. doi: 10.1007/s00228-014-1704-z.
    1. Shapiro D.J., Hicks L.A., Pavia A.T., Hersh A.L. Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09. J. Antimicrob. Chemother. 2014;69:234–240. doi: 10.1093/jac/dkt301.
    1. van der Velden A.W., Kuyvenhoven M.M., Verheij T.J. Improving antibiotic prescribing quality by an intervention embedded in the primary care practice accreditation: The ARTI4 randomized trial. J. Antimicrob. Chemother. 2016;71:257–263. doi: 10.1093/jac/dkv328.
    1. Panasiuk L., Lukas W., Paprzycki P., Verheij T., Godycki-Cwirko M., Chlabicz S. Antibiotics in the treatment of upper respiratory tract infections in Poland. Is there any improvement? J. Clin. Pharm. Ther. 2010;35:665–669. doi: 10.1111/j.1365-2710.2009.01136.x.
    1. Thompson M., Vodicka T.A., Blair P.S., Buckley D.I., Heneghan C., Hay A.D. Duration of symptoms of respiratory tract infections in children: Systematic review. BMJ. 2013;347:f7027. doi: 10.1136/bmj.f7027.
    1. Dickerson L.M., Mainous A.G., 3rd, Carek P.J. The pharmacist’s role in promoting optimal antimicrobial use. Pharmacotherapy. 2000;20:711–723. doi: 10.1592/phco.20.7.711.35171.
    1. World Health Organization . The Role of Pharmacist in Encouraging Prudent Use of Antibiotics and Averting Antimicrobial Resistance: A Review of Policy and Experience 2014. World Health Organization; Geneva, Switzerland: 2014.
    1. Vazquez-Lago J., Gonzalez-Gonzalez C., Zapata-Cachafeiro M., Lopez-Vazquez P., Taracido M., López A., Figueiras A. Knowledge, attitudes, perceptions and habits towards antibiotics dispensed without medical prescription: A qualitative study of Spanish pharmacists. BMJ Open. 2017;7:e015674. doi: 10.1136/bmjopen-2016-015674.
    1. Roque F., Soares S., Breitenfeld L., Figueiras A., Herdeiro M.T. Influence of community pharmacists attitudes on antibiotic dispensing behavior: A cross-sectional study in Portugal. Clin Ther. 2015;37:168–177. doi: 10.1016/j.clinthera.2014.11.006.
    1. Ghiga I., Stalsby Lundborg C. ‘Struggling to be a defender of health’ -a qualitative study on the pharmacists’ perceptions of their role in antibiotic consumption and antibiotic resistance in Romania. J. Pharm. Policy Pract. 2016;9:10. doi: 10.1186/s40545-016-0061-y.
    1. Finch R.G., Metlay J.P., Davey P.G., Baker L.J., colloquium IFoAR Educational interventions to improve antibiotic use in the community: Report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect. Dis. 2004;4:44–53. doi: 10.1016/S1473-3099(03)00860-0.
    1. Madle G., Kostkova P., Mani-Saada J., Weinberg J., Williams P. Changing public attitudes to antibiotic prescribing: Can the internet help? Inform. Prim. Care. 2004;12:19–26. doi: 10.14236/jhi.v12i1.104.
    1. Roque F., Teixeira-Rodrigues A., Breitenfeld L., Pineiro-Lamas M., Figueiras A., Herdeiro M.T. Decreasing antibiotic use through a joint intervention targeting physicians and pharmacists. Future Microbiol. 2016;11:877–886. doi: 10.2217/fmb-2016-0010.
    1. World Health Organization . Pharmaceuticals in Drinking Water. World Health Organization; Geneva, Switzerland: 2012.
    1. European Parliament DRAFT REPORT on a European One Health Action Plan against Antimicrobial Resistance (AMR) 2018. [(accessed on 28 November 2018)]; Available online: .
    1. World Health Organization Country Progress in the Implementation of the Global Action Plan on Antimicrobial Resistance: WHO, FAO and OIE Global Tripartite Database 2017. [(accessed on 28 November 2018)]; Available online:
    1. Access to Medicines Fundation First Independent Framework for Assessing Pharma Company Action on AMR 2017. [(accessed on 28 November 2018)]; Available online:
    1. Sparrow E., Friede M., Sheikh M., Torvaldsen S. Therapeutic antibodies for infectious diseases. Bull. World Health Organ. 2017;95:235–237. doi: 10.2471/BLT.16.178061.
    1. Årdal C.O., Findlay D., Savic M., Carmeli Y., Gyssens I., Laxminarayan R., Outterson K., Rex J.H. Revitalizing the Antibiotic Pipeline. Stimulating Innovation While Driving Sustainable Use and Global Access. DRIVE-AB; London, UK: 2018.
    1. Biomedical Advanced Research and Development Authority (BARDA) [(accessed on 28 November 2018)]; Available online: .
    1. Generating Antibiotic Incentives Now (GAIN) [(accessed on 28 November 2018)]; Available online: .
    1. EPHA Joint Statement on Antimicrobial Resistance (AMR) 2017. [(accessed on 28 November 2018)]; Available online: .

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe